Article
Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
4 Jul 2023
Abstract excerpt
Transient delivery of CRISPR-Cas9 ribonucleoproteins (RNPs) into the central nervous system (CNS) for therapeutic genome editing could avoid limitations of viral vector-based delivery including cargo capacity, immunogenicity, and cost. Here, we tested the ability of cell-penetrant Cas9 RNPs to edit the mouse striatum when introduced using a convection-enhanced delivery system. These transient Cas9 RNPs showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
